Our studies showed that temsirolimus, an inhibitor of mTOR [14], reduced cancer cell growth slightly, but did not cause cell death against the “resistant” type of renal cell carcinomas under glucose deprivation (Figure 4D). Here, MTOR is linked to renal cell carcinoma.